Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference65 articles.
1. Molecular mechanisms of drug resistance and its reversal in cancer;Kartal-Yandim;Crit Rev Biotechnol,2016
2. Targeting multidrug resistance in cancer;Szakács;Nat Rev Drug Discov,2006
3. The multidrug resistance phenotype;Kaye;Br J Cancer,1988
4. ABC efflux pump-based resistance to chemotherapy drugs;Eckford;Chem Rev,2009
5. Multidrug resistance in cancer: role of ATP–dependent transporters;Gottesman;Nat Rev Cancer,2002
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Animal-derived natural products for hepatocellular carcinoma therapy: current evidence and future perspectives;Frontiers in Pharmacology;2024-05-09
2. Natural products for combating multidrug resistance in cancer;Pharmacological Research;2024-04
3. Epoxide of diosgenin acetate synthesis: DoE for diastereoselective yield optimization, antimicroibial, antioxidant and antiproliferative effects;Steroids;2023-09
4. Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response;BMC Complementary Medicine and Therapies;2023-05-18
5. Bixin and fuxoxanthin alone and in combination with cisplatin regulate ABCC1 and ABCC2 Transcription in A549 Lung Cancer Cells;Journal of Pharmacy And Bioallied Sciences;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3